Monoclonal Antibodies: Anti-human C5a Receptor (C5aR / CD88); anti-C5aR-pSer334 (PKC site) mAb
Scientists at the Georg-August-University Göttingen produced different monoclonal antibodies directed against phosphorylation sites of C5aR. Using these antibodies the activation state of C5aR can be directly measured in tissue or cultured cells.
Since the relevant epitope is known to be phosphorylated by Protein Kinase C (PKC), this principle can also be used to measure PKC activity or to screen for new PKC inhibitors. CD88 is expressed by peripherial blood granulocytes and monocytes. Binding of C5a (fragment of the complement factor C5) to CD88 leads to cellular activation, including chemotaxis.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Recovering phosphorus from sewage sludge ash
Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…
